Skip to content
OpenCapital
Get started

LifeStance Health Group LFST Business Combination Remeasurement Gain Loss On Contingent Consideration

Business Combination Remeasurement Gain Loss On Contingent Consideration at other companies

Iron Mountain logo
Iron MountainIRM
-$17.84M—
Vertex, Inc. logo
Vertex, Inc.VERX
-$5.74M+61.0%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$179K+117%
Haemonetics logo
HaemoneticsHAE
-$469.75K+91.8%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
-$182K+98.5%
e.l.f. Beauty logo
e.l.f. BeautyELF
$14.41M—

Other financials

Income statement

See full
Revenue$403.5M+21.2%
Operating income$22.3M+1,289%
Net income$14.2M+1,909%
EPS (diluted)$0.04—

Balance sheet

See full
Cash & equivalents$194.8M+45.0%
Total debt$476.8M-1.1%
Total equity$1.5B+1.4%
Total assets$2.1B+2.0%

Cash flow

See full
Operating cash flow$33.1M+1,171%
CapEx$10.8M+50.2%
Free cash flow$22.3M+318%

Valuation

See full
Market cap$3.6B-4.8%

Profitability

See full
Operating margin3%+2.4pp
Net margin1.6%+1.0pp
FCF margin9.5%+1.6pp

Returns & leverage

See full
Return on equity1.6%+1.0pp
Debt / equity0.3×0.0×
Current ratio1.5×0.0×

Where this comes from

Reported directly by LifeStance Health Group in its filing.

Tagged under the XBRL concept lfst:BusinessCombinationRemeasurementGainLossOnContingentConsideration.

The official record: LifeStance Health Group’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about LifeStance Health Group's business combination remeasurement gain loss on contingent consideration.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LifeStance Health Group's business combination remeasurement gain loss on contingent consideration?
LifeStance Health Group (LFST) reported business combination remeasurement gain loss on contingent consideration of -$5K in Q1 2026.
What is the long-term trend for LifeStance Health Group's business combination remeasurement gain loss on contingent consideration?
Over 2 years (2021 to 2025), LifeStance Health Group's business combination remeasurement gain loss on contingent consideration has grown at a -100.0% compound annual growth rate (CAGR), from -$2.61M to $0.
What does business combination remeasurement gain loss on contingent consideration mean?
This reflects the periodic adjustment in the fair value of contingent consideration liabilities related to past acquisitions. It captures the impact of changes in expected earn-out payments based on the performance of acquired practices. Investors use this to assess the accuracy of initial acquisition valuations and the ongoing financial impact of integration performance.